CUSIP: 78470E205
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / MSCI EMR MKT ETF
-
Total 13F shares
-
148,239
-
Share change
-
-117,271
-
Total reported value
-
$9,276,000
-
Price per share
-
$62.58
-
Number of holders
-
16
-
Value change
-
-$7,323,816
-
Number of buys
-
8
-
Number of sells
-
5
Security key
78470E205
Report period
Q2 2019
Institutions
16
Top holders
10
Reporting periods
Holder history for CUSIP 78470E205
Recent filing periods:
Top shareholders of EEMX - SPDR INDEX SHS FDS - MSCI EMR MKT ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) as of Q2 2019
As of 30 Jun 2019,
SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
148,239 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, JANE STREET GROUP, LLC, GOLDMAN SACHS GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, Hanson & Doremus Investment Management, BALDWIN BROTHERS INC/MA, Miracle Mile Advisors, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Cribstone Capital Management, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor |
Q1 2019 Shares |
Q2 2019 Shares |
Share Diff |
Share Chg % |
Q1 2019 Value $ |
Q2 2019 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.